Complicated Intra-Abdominal Infections Clinical Trial
Official title:
Risk Factors for Colonization and Infection With Antibiotic Resistant Bacteria Among Patients With Severe Intraabdominal Infections (IAI). An Open Observational Study
The objectives of the study were:
1. To study risk factors for colonization and infection with antibiotic resistant bacteria
among patients with severe IAI before and after antibiotic treatment and surgical
intervention.
2. To study species changes in the rectal flora among patients with severe IAI before and
after antibiotic treatment and surgical intervention.
3. To review guidelines for antibiotic use in participating units.
4. To evaluate surgical antibiotic prophylaxis and treatment in relation to risk for
colonization and infection with antibiotic resistant bacteria among patients with
severe IAI
5. To use the results from the study in the process of a more appropriate use of
antibiotics in participating units and care of patients with severe IAI.
6. To study the dynamics of extended-spectrum beta-lactamase producing and wild-type
Enterobacteriaceae in patients with suspected severe intra abdominal infections before,
during and after antibiotic treatment.
In order to evaluate if standard empirical treatment was adequate in relation to resistance pattern among most prevalent species at admission we need another 70 patients to be included with at least data and cultures from admission. ;
Observational Model: Case-Only, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00389987 -
Ertapenem Sodium vs. Piperacillin/Tazobactam in the Treatment of Complicated Intra-Abdominal Infections (0826-037)
|
Phase 3 | |
| Completed |
NCT02784704 -
Efficacy and Safety Study of Eravacycline Compared With Meropenem in Complicated Intra-abdominal Infections
|
Phase 3 | |
| Completed |
NCT01072539 -
Study Evaluating The Safety And Effectiveness In Subjects With Tigecycline Treatment
|
||
| Completed |
NCT00752219 -
Prospective Multicenter Doubleblind Randomized Study of NXL104/Ceftazidime + Metronidazole vs. Meropenem in Treatment of Complicated Intra-abdominal Infections
|
Phase 2 | |
| Completed |
NCT03830333 -
Ceftolozane/Tazobactam (MK-7625A) Plus Metronidazole Versus Meropenem for Participants With Complicated Intra-abdominal Infection (MK-7625A-015)
|
Phase 3 | |
| Not yet recruiting |
NCT03678298 -
Italian Register for the Study of Complicated Intra-Abdominal Infections
|
||
| Completed |
NCT01844856 -
Efficacy and Safety Study of Eravacycline Compared With Ertapenem in Complicated Intra-abdominal Infections
|
Phase 3 | |
| Completed |
NCT02475733 -
Evaluation of Safety,Pharmacokinetics and Efficacy of CAZ-AVI With Metronidazole in Children Aged 3 Months to 18 Years Old With Complicated Intra-abdominal Infections (cIAIs).
|
Phase 2 | |
| Completed |
NCT00683332 -
Post-Marketing Study Of The Safety Of Tygacil (Tigecycline)
|
N/A |